Answers are grounded in this paper and cite their sources.
Xylazine-related wounds are increasingly presenting an addiction medicine and surgical dilemma in people who use drugs. Initially developed as a veterinary sedative, xylazine has been found increasingly added to illicitly manufactured fentanyl, reportedly to extend the duration of fentanyl intoxication. On the street, xylazine-laced fentanyl is known as “tranq,” “tranq dope,” and “zombie drug.” The management of xylazine-associated wounds needs multidisciplinary care. To better understand the scope of this new problem, review the best current evidence, and reach a consensus on best practices to manage xylazine-associated wounds, a formal consensus meeting was held, and the findings are presented here in this current concepts review.
No takes yet. Share an insight, caveat, or question.
Ilyas et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: